Zentalis Pharmaceuticals (ZNTL) Change in Receivables (2019 - 2025)
Zentalis Pharmaceuticals' (ZNTL) quarterly Change in Receivables came in at -$5.0 million in Q1 2025, down 200.0% quarter-over-quarter from $5.0 million in Q4 2024.
Zentalis Pharmaceuticals (ZNTL) Change in Receivables (2019 - 2025) Analysis & Trends
Zentalis Pharmaceuticals' Change in Receivables history runs 6 years deep, the most recent figure standing at -$5.0 million for Q1 2025.
- On a quarterly basis, Change in Receivables changed N/A year-over-year to -$5.0 million in Q1 2025; TTM through Dec 2025 was -$5.0 million, a 200.0% decrease from a year earlier, with the FY2025 full-year figure at -$5.0 million, down 200.0% from the prior year.
- Change in Receivables declined to -$5.0 million in Q1 2025 per ZNTL's latest filing, from $5.0 million in the prior quarter.
- Across five years, Change in Receivables topped out at $5.0 million in Q4 2024 and bottomed at -$5.0 million in Q1 2025.
- The 4-year median for Change in Receivables is -$104000.0 (2021), against an average of -$58428.6.
- Biggest YoY gain for Change in Receivables was 110.2% in 2021; the steepest drop was 16800.0% in 2021.
- Year by year, Change in Receivables stood at -$104000.0 in 2021, then surged by 103.85% to $4000.0 in 2022, then soared by 124900.0% to $5.0 million in 2024, then sank by 200.0% to -$5.0 million in 2025.
- Per Business Quant, the three latest ZNTL Change in Receivables figures stand at -$5.0 million (Q1 2025), $5.0 million (Q4 2024), and $4000.0 (Q4 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zentalis Pharmaceuticals | 312.67 Mn | 312.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -5.00 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2021 | -104,000.00 |
| Dec 31, 2021 | -104,000.00 |
| Sep 30, 2021 | 103,000.00 |
| Sep 30, 2021 | 103,000.00 |
| Jun 30, 2021 | -243,000.00 |
| Jun 30, 2021 | -243,000.00 |
| Mar 31, 2021 | -169,000.00 |
| Mar 31, 2021 | -169,000.00 |
| Dec 31, 2020 | 295,000.00 |
| Dec 31, 2020 | 295,000.00 |
| Sep 30, 2020 | 49,000.00 |
| Sep 30, 2020 | 49,000.00 |
| Jun 30, 2020 | -66,000.00 |
| Jun 30, 2020 | -66,000.00 |